Key Insights

Highlights

Success Rate

98% trial completion (above average)

Published Results

41 trials with published results (15%)

Research Maturity

186 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

1.5%

4 terminated out of 266 trials

Success Rate

97.9%

+11.4% vs benchmark

Late-Stage Pipeline

44%

116 trials in Phase 3/4

Results Transparency

22%

41 of 186 completed with results

Key Signals

41 with results98% success

Data Visualizations

Phase Distribution

235Total
Not Applicable (45)
Early P 1 (2)
P 1 (37)
P 2 (35)
P 3 (80)
P 4 (36)

Trial Status

Completed186
Unknown48
Recruiting14
Not Yet Recruiting9
Terminated4
Active Not Recruiting3

Trial Success Rate

97.9%

Benchmark: 86.5%

Based on 186 completed trials

Clinical Trials (266)

Showing 20 of 20 trials
NCT06778239Recruiting

Childhood-Onset Essential Hypertension Natural History Study

NCT07577323Not ApplicableNot Yet RecruitingPrimary

Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension

NCT06682000Phase 3Completed

Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension

NCT01566188Not ApplicableCompletedPrimary

Vascular Impact of Omega-3 in Metabolic Syndrome

NCT06671392Phase 3CompletedPrimary

A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension

NCT03857490Not ApplicableCompletedPrimary

Heat Therapy in Older Hypertensive Women

NCT06287580Early Phase 1CompletedPrimary

Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.

NCT07433790Not ApplicableCompleted

Mat Pilates With Paced Breathing Versus Diaphragmatic Breathing in Stage II Hypertension

NCT07424118Not ApplicableNot Yet RecruitingPrimary

REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription

NCT07421414Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

NCT07421401Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

NCT07421388Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions

NCT07421375Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

NCT06041529Phase 4Active Not RecruitingPrimary

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

NCT01022515Not ApplicableCompleted

Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma

NCT07373613Phase 2Not Yet RecruitingPrimary

A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension

NCT07282145Phase 1RecruitingPrimary

Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

NCT06643819Phase 3RecruitingPrimary

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

NCT06418074Not ApplicableCompleted

Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity

NCT07257237Not ApplicableCompletedPrimary

Sleep Hygiene Education and Blood Pressure Control in Essential Hypertension in Primary Care

Scroll to load more

Research Network

Activity Timeline